- Home
- >1910 Genetics

1910 Genetics
Make undruggable targets a thing of the past
Company
Website
http://1910genetics.comLocations
Cambridge, MA, USA
Team Size
14
Industries
Healthcare, Therapeutics
About
We are a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Our mission is to decrease the timeline and cost of drug development, while improving the success rate of bring innovative medicines to patients in need.
We have two drug discovery engines - ELVIS™ and ROSALYND™ - that enable the design of both small molecule and protein therapeutics, an unmatched capability in the AI drug discovery space. Our therapeutic area-agnostic, end-to-end technology powers the full length of early drug discovery - from novel hit discovery to hit to lead, and lead optimization.
We are currently applying our technology to drug discovery programs in several areas including, but not limited to, neuroscience, infectious disease, immunology and oncology.
Founders
A list of all active founders
Sign-In
An account is required to download data from YCRM.
Almost There!
YCRM requires a one-time $30 payment to get access.
What You Get
- Unlimited downloads for 30 days
- 5000+ YC founders' email, LinkedIn, and Twitter
- Access to the latest YC batches
- Access to all CRM data enhancements
Payment Successful
Congrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help.
Name | Title | |||
---|---|---|---|---|
Jen Nwankwo | CEO | Sign-InAn account is required to download data from YCRM. Almost There!YCRM requires a one-time $30 payment to get access. What You Get
Payment SuccessfulCongrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help. |